125 related articles for article (PubMed ID: 3923141)
1. Purification and characterization of placental plasminogen activator (PPA).
Kobayashi T; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
[TBL] [Abstract][Full Text] [Related]
2. The role of placental urokinase inhibitor in toxemia of pregnancy.
Terao T; Kobayashi T
Biol Res Pregnancy Perinatol; 1983; 4(4):145-51. PubMed ID: 6360225
[TBL] [Abstract][Full Text] [Related]
3. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
Nulkar MW; Pawse AR
Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
[TBL] [Abstract][Full Text] [Related]
4. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
[TBL] [Abstract][Full Text] [Related]
5. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen-activator in human early milk: its partial purification and characterization.
Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
[TBL] [Abstract][Full Text] [Related]
7. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
[TBL] [Abstract][Full Text] [Related]
8. Characterization of plasminogen activator from two human renal carcinoma cell lines.
Nelson NF; Cieplak W; Dacus SC; Prager MD
J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
10. Isolation of tissue plasminogen activator from skin lesions with allergic vasculitis.
Toki N; Tsushima H; Yamasaki M; Yamasaki R; Yamura T
J Invest Dermatol; 1982 Jan; 78(1):18-23. PubMed ID: 7198668
[TBL] [Abstract][Full Text] [Related]
11. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
Wun TC; Reich E
J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
[TBL] [Abstract][Full Text] [Related]
12. Characterization of plasminogen activator produced by an established cell line from human ovary.
Matsuo C; Fukao H; Matsuo O
J Cell Physiol; 1988 Feb; 134(2):253-60. PubMed ID: 3126195
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the immunohistochemical localization of coagulation fibrinolysis factors in the placenta, especially of placental plasminogen activator (PPA)].
Kyodo Y; Kobayashi T; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):10-6. PubMed ID: 3512741
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
Bykowska K; Rijken DC; Collen D
Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
[TBL] [Abstract][Full Text] [Related]
15. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
Shevelev AIa; Barshevskaia TN; Belogurov AA; Kratasiuk GA; Goriunova LE
Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
[TBL] [Abstract][Full Text] [Related]
16. [Purification and properties of plasminogen activator from human blood plasma after sudden death].
Petrenko OA
Biokhimiia; 1978 Aug; 43(8):1438-43. PubMed ID: 153771
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation.
Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
Thromb Haemost; 1985 Aug; 54(2):485-9. PubMed ID: 3936218
[TBL] [Abstract][Full Text] [Related]
18. Partial purification and characterization of native plasminogen activators from bovine milk.
Deharveng G; Nielsen SS
J Dairy Sci; 1991 Jul; 74(7):2060-72. PubMed ID: 1894805
[TBL] [Abstract][Full Text] [Related]
19. On a plasminogen activator from human plasma.
Batista AD; Solana GH; Almonte JF
Thromb Haemost; 1980 Feb; 42(5):1607-14. PubMed ID: 6899948
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
Camiolo SM; Greco WR
Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]